NBY - NovaBay Pharma receives non-compliance letter from NYSE

• NovaBay Pharmaceuticals ( NYSE: NBY ) said it had received a notice from the NYSE that its stock had been selling for a low price per share for a substantial period of time.
• Under the NYSE guide, the company could either do a reverse stock split of its stock or show a sustained price improvement within a reasonable period of time before April 3, 2023, in order to continue its listing.
• The company plans to hold a Special Meeting of Stockholders on November 10, seeking stockholder authorization of a reverse stock split at a ratio of between 1-for-10 and 1-for-35.

For further details see: